Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 135.50
+1.00 (0.74%)
Aug 14, 2025, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 210.16 billion as of August 14, 2025. Its market cap has increased by 107.92% in one year.
Market Cap
210.16B
Enterprise Value
200.77B
Revenue
44.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
135.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 210.16B, an increase of 2,540.77%. That is a compound annual growth rate of 246.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 210.16B | 122.71% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 165.97B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.66B |
| Oneness Biotech | 32.23B |
| Polaris Group | 27.47B |
| Lumosa Therapeutics | 27.18B |
| Center Laboratories | 26.42B |
| Pegavision | 24.77B |